IRIS
DI MUZIO, NADIA GISELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.267
NA - Nord America 850
AS - Asia 680
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 2
Totale 2.815
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 842
SE - Svezia 594
CN - Cina 352
SG - Singapore 286
IT - Italia 280
RU - Federazione Russa 207
FI - Finlandia 60
IE - Irlanda 30
DE - Germania 27
NL - Olanda 24
IN - India 11
IR - Iran 9
AU - Australia 8
BE - Belgio 8
ES - Italia 8
EU - Europa 7
HK - Hong Kong 7
AT - Austria 6
CA - Canada 6
GB - Regno Unito 6
FR - Francia 5
TH - Thailandia 5
TR - Turchia 4
AL - Albania 2
BR - Brasile 2
CH - Svizzera 2
JP - Giappone 2
PL - Polonia 2
UA - Ucraina 2
AZ - Azerbaigian 1
BD - Bangladesh 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GR - Grecia 1
JO - Giordania 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
MX - Messico 1
NZ - Nuova Zelanda 1
Totale 2.815
Salva come PNG Salva come JPEG
Città #
Shanghai 252
Lawrence 203
Princeton 201
Singapore 178
Ashburn 138
Milan 110
Moscow 68
New York 64
Helsinki 52
Dublin 30
Boardman 26
Rome 26
Los Angeles 12
Guangzhou 10
Washington 10
Dallas 9
Pune 9
Shenzhen 9
West Jordan 8
Amsterdam 7
Bologna 7
Genoa 7
Seattle 7
Borås 6
Cassina de' Pecchi 6
Jiaxing 6
Meppel 6
Santa Clara 6
Espoo 5
Sydney 5
Bangkok 4
Beijing 4
Bitetto 4
Brussels 4
Abbotsford 3
Canberra 3
Canegrate 3
Caserta 3
Chicago 3
Council Bluffs 3
Ferrara 3
Gatchina 3
Hanover 3
Knaresborough 3
Lappeenranta 3
Naples 3
Oshnaviyeh 3
Vicenza 3
Andover 2
Aprilia 2
Bari 2
Bergamo 2
Berlin 2
Beveren 2
Bolzano 2
Castenaso 2
Corbera de Llobregat 2
Esparreguera 2
Falkenstein 2
Francavilla al Mare 2
Frankfurt am Main 2
Fuzhou 2
Gilbert 2
Hong Kong 2
Jena 2
Kish 2
Lissone 2
Livorno 2
Mestre 2
Modena 2
Mountain View 2
Palermo 2
Paullo 2
Pavia 2
Perugia 2
Pregassona 2
Roseto degli Abruzzi 2
Tirana 2
Tokyo 2
Toronto 2
Verdellino 2
Vienna 2
Amman 1
Anshan 1
Augusta 1
Baku 1
Bordeaux 1
Cagliari 1
Campodolcino 1
Cavallino 1
Central District 1
Changsha 1
Civitavecchia 1
Curitiba 1
Dhaka 1
Elmendorf 1
Florence 1
Foshan 1
Gioia del Colle 1
Gothenburg 1
Totale 1.627
Salva come PNG Salva come JPEG
Nome #
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 83
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 61
Early regression index (ERI) on MR images as response predictor in esophageal cancer treated with neoadjuvant chemo-radiotherapy: interim analysis of the prospective ESCAPE trial 50
Health-related quality of life 24 months after prostate cancer diagnosis: An update from the Pros-IT CNR prospective observational study 46
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 44
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 39
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 39
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 33
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 31
La qualità della vita del paziente col tumore alla prostata sottoposto a trattamento radioterapico: uno studio prospettico 31
null 31
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 30
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 28
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 27
Equipment, staffing, and provision of radiotherapy in Lombardy, Italy: Results of three surveys performed between 2012 and 2016 26
Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression index 25
[C-11]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 24
A non-invasive ultrasound imaging method to measure acute radiation-induced bladder wall thickening in rats 24
Prostate cancer with low burden skeletal disease at diagnosis: outcome of concomitant radiotherapy on primary tumor and metastases 24
Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study 22
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 22
Abiraterone and ionizing radiation alter the sphingolipid homeostasis in prostate cancer cells 22
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study 22
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience 21
Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: A comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and Helical Tomotherapy 21
Adenoid cystic carcinoma of trachea treated with adjuvant hypofractionated tomotherapy. Case report and literature review 21
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 21
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects 21
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging 21
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 20
18Fluorodeoxyglucose Positron Emission Tomography (18FDG-PET)-Guided Target Delineation in Lung Cancer 20
A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer 20
Replacing Manual Planning of Whole Breast Irradiation With Knowledge-Based Automatic Optimization by Virtual Tangential-Fields Arc Therapy 19
Patients with Cardiac Implantable Electronic Device Undergoing Radiation Therapy: Insights from a Ten-Year Tertiary Center Experience 19
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients 19
Quality indicators in the intensity modulated/image-guided radiotherapy era 19
Ocular leukemic mass-like relapse treated with CyberKnife stereotactic radiosurgery 19
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 18
Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumor. 18
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients 18
Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study 18
Predicting pathological response after radio-chemotherapy for rectal cancer: Impact of late oxaliplatin administration 18
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 18
OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO 18
Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study 18
Neoadjuvant chemoradiotherapy in patients with esopageal or esophageal gastric junction cancer 18
Could early tumour volume changes assessed on morphological MRI predict the response to chemoradiation therapy in locally-advanced rectal cancer? 17
IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy 17
A two-variable linear model of parotid shrinkage during IMRT for head and neck cancer 17
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 17
Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients 17
Oligometastatic disease in prostate cancer, a continuously changing paradigm: Patient selection and treatment strategy 17
Hypofractionated 4D-PET/CT-based helical tomotherapy for the treatment of lung metastases: A feasibility study 17
Management of radiation-induced oral mucositis in head and neck cancer patients: a real-life survey among 25 Italian radiation oncology centers 16
Re: Daniel E. Spratt, Herbert A. Vargas, Zachary S. Zumsteg, et al. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. Eur Urol 2017;71;37–43: High-dose Radiotherapy and Pelvic Lymph Nodal Irradiation for High-risk Prostate Cancer in the Image-guided Radiotherapy Era 16
Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial 16
Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis 15
PET/CT for radiotherapy: image acquisition and data processing 15
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row: Nodal oligorecurrent prostate cancer 15
Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation 15
Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy 15
Inflammatory pseudotumor of mediastinum treated with tomotherapy and monitored with FDG-PET/CT: case report and literature review 15
The relationship between local recurrences and distant metastases in prostate cancer: can11C-choline PET/CT contribute to understand the link? 15
Defining the Right State for a Will Rogers Phenomenon in Oligometastatic Prostate Cancer 15
Pre-clinical Research on Bladder Toxicity After Radiotherapy for Pelvic Cancers: State-of-the Art and Challenges 15
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy 15
Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer 14
Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer Patients 14
Predictors of patient-reported incontinence at adjuvant/salvage radiotherapy after prostatectomy: Impact of time between surgery and radiotherapy 14
Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: A mono-institutional experience 14
ADJUVANT RADIOTHERAPY LEADS TO SUPERIOR BIO-CHEMICAL RECURRENCE FREE SURVIVAL COMPARED TO EARLY SALVAGE RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER: RESULTS OF A MATCHED-CONTROLLED MULTI-INSTITUTIONAL ANALYSIS 14
IL GLEASON SCORE PATOLOGICO INFLUENZA FORTEMENTE LA SOPRAVVIVENZA IN PAZIENTI CON INVASIONE DELLE VESCICOLE SEMINALI SOTTOPOSTI A PROSTATECTOMIA RADICALE E RADIOTERAPIA ADIUVANTE 14
SOPRAVVIVENZA CANCRO-SPECIFICA DEI PAZIENTI CON RIPRESA BIOCHIMICA DI MALATTIA DOPO PROSTATECTOMIA RADICALE E RADIOTERAPIA ADIUVANTE PER TUMORE PROSTATICO LOCALMENTE AVANZATO 14
Segmentation of FDG PET lung lesions based on a thresholding approach for BTV definition 14
Application of failure mode and effects analysis (FMEA) to pretreatment phases in tomotherapy 14
Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy 14
Early volume variation of positive lymph nodes assessed by in-room mega voltage CT images predicts risk of loco-regional relapses in head and neck cancer patients treated with intensity-modulated radiotherapy 14
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 14
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 14
Clinical implementation of low-dose total body irradiation using topotherapy technique 14
Reply to Salvador Vale's Letter to the Editor re: Cesare Cozzarini. Whole-pelvis Radiotherapy in the Radiation Treatment of Intermediate- and High-risk Prostate Cancer: How to Improve the Therapeutic Ratio of a Potentially Effective but still Unsatisfactory Treatment? Eur Urol 2017;71:44–5. Preclinical Combinatory Approach to Enhance Radiotherapy Effects and Reduce its Morbidity may be Tested in the Clinic: Wider Whole-pelvis Radiotherapy Fields and Enhanced Antitumoral Effect Mediated by T Lymphocytes: A Legitimate Hypothesis? 14
Skin Dose Variations during Tomotherapy for Head and Neck Cancer Patients: Need for Adaptive Replanning? 14
Significant reduction of acute toxicity following pelvic irradiation with Helical Tomotherapy in patients with localized prostate cancer 13
PET/CT guided helical tomotherapy in patients with locally advanced pancreatic cancer 13
Changes in glucose metabolism during and after radiotherapy in non-small cell lung cancer 13
Thresholding segmentation of FDG PET lung lesions for RT planning purposes 13
Integration of Diffusion Magnetic Resonance Tractography into tomotherapy radiation treatment planning for high-grade gliomas 13
Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison 13
Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study 13
Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer 13
Remission of refractory neurosarcoidosis treated with brain radiotherapy: a case report and a literature review 13
Static and rotational intensity modulated techniques for head-neck cancer radiotherapy: a planning comparison 13
Hematologic Toxicity in Patients Treated With Postprostatectomy Whole-Pelvis Irradiation With Different Intensity Modulated Radiation Therapy Techniques Is Not Negligible and Is Prolonged: Preliminary Results of a Longitudinal, Observational Study 13
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 13
Characterisation of rectal motion during neo-adjuvant radiochemotherapy for rectal cancer with image-guided tomotherapy: implications for adaptive dose escalation strategies 13
Knowledge-based automatic optimization of adaptive early-regression-guided VMAT for rectal cancer 13
Head and neck radiotherapy amid the COVID-19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 13
Virtual Tangential-fields Arc Therapy (ViTAT) for whole breast irradiation: Technique optimization and validation 13
Outcome of adjuvant hypofractionated radiotherapy concomitant to chemotherapy in bile duct carcinoma 12
PET/CT with [18F]FDG to evaluate the response to helical tomotherapy in NSCLC and lung metastases 12
Totale 2.000
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.614
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 1 0 1 0 3 1 1
2020/202182 0 0 0 15 0 50 6 1 0 0 1 9
2021/2022145 0 0 2 88 4 7 10 8 12 6 1 7
2022/20231.108 472 233 75 6 0 117 42 77 46 5 11 24
2023/2024675 11 35 59 127 46 113 22 54 18 42 53 95
2024/2025970 431 72 53 117 105 192 0 0 0 0 0 0
Totale 3.091